Company Filing History:
3 out of 13 
2 out of 3,923 
2 out of 2,611 
Years Active: 2020-2024
Title: Qiumei Yang: Innovator in Antibody and Gene Therapy
Introduction
Qiumei Yang is a prominent inventor based in Shanghai, China, known for his significant contributions to the fields of biotechnology and medicine. With a total of five patents to his name, Yang has focused on developing innovative solutions for treating autoimmune diseases and cancer.
Latest Patents
Yang's latest patents include groundbreaking work on anti-CXCL13 antibodies for treating autoimmune diseases and cancer. This invention provides antibodies or fragments that specifically bind to the human chemokine (C-X-C motif) ligand 13 (CXCL13) protein. The patents also detail methods for using these antibodies in treating various autoimmune diseases and disorders. Another notable patent involves phosphoglycerate kinase 1 (PGK) promoters and methods for expressing chimeric antigen receptors (CARs). This invention includes compositions and methods for treating diseases associated with tumor antigen expression, as well as nucleic acids linked to CARs specific to tumor antigens.
Career Highlights
Throughout his career, Qiumei Yang has worked with leading companies in the pharmaceutical industry, including I-Mab Biopharma and Novartis AG. His work has significantly advanced the understanding and treatment of complex diseases, showcasing his expertise in the field.
Collaborations
Yang has collaborated with notable professionals in his field, including Jennifer Brogdon and Hilmar Erhard Ebersbach. These collaborations have further enriched his research and development efforts.
Conclusion
Qiumei Yang's innovative work in antibody and gene therapy continues to pave the way for new treatments in medicine. His contributions are vital in addressing some of the most challenging health issues today.